Frequency of Hyperlipidemia in Type 2 Diabetes Mellitus Patients with Microalbuminuria
DOI:
https://doi.org/10.51253/pafmj.v74i2.7580Keywords:
Diabetes Mellitus, Hyperlipidemia, MicroalbuminuriaAbstract
Objective: To evaluate the frequency of hyperlipidemia in type 2 diabetes mellitus (DM) patients with microalbuminuria attending a tertiary care hospital.
Study Design: Cross-sectional study
Place and Duration of Study: Combined Military Hospital, Jhelum Pakistan, from Jan 2020 to Feb 2021.
Methodology: All patients aged 30 years or above with type 2 DM mellitus presented with or without microalbuminuria were consecutively enrolled. Hyperlipidemia was defined based on the presence of an elevated lipid profile. This information, along with baseline and other predicting factors, was noted.
Results: Of 236 patients, hyperlipidemia was observed in 107(45.3%) patients with type 2 DM having microalbuminuria. The odds of hyperlipidemia were 53% less likely among patients aged ≤59 years than that of patients aged>59 years [aOR: 0.47, 95% CI: 0.27-0.85], 47% less likely among patients with ≤7 years of diabetes duration as compared to >7 years of duration of diabetes [aOR: 0.53, 95% CI: 0.29-0.96], and 75% less likely among patients with ≤140 mm Hg SBP as compared to the patients with >140 mm Hg SBP [aOR: 0.25, 95% CI: 0.14-0.46].
Conclusion: In the current study, hyperlipidemia was observed to be considerably higher in patients with type 2 DM having microalbuminuria. Moreover, elderly patients, longer diabetes duration, and elevated blood pressure are some of the risk factors reported in our patients.
Downloads
References
Roden M, Shulman GI. The integrative biology of type 2 diabetes.
Nature 2019; 576(7785): 51-60.
https://doi.org/10.1038/s41586-019-1797-8
Bommer C, Sagalova V, Heesemann E, Manne-Goehlr J, Atun R,
Bärnighausen T, et al. Global Economic Burden of Diabetes in
Adults: Projections From 2015 to 2030. Diabetes Care 2018; 41(5):
-970.
https://doi.org/10.2337/dc17-1962
Reddy V, Inamdar P. A comparative study of foot infections in
diabetic and non-diabetic patients with reference to
etiopathogenesis, clinical features and outcome. Int Surg J 2020;
(5): 1496-1502. https://doi.org/10.18203/2349-2902.isj20201858
Niemann U, Spiliopoulou M, Malanowski J, Kellersmann J,
Szczepanski T, Klose S, et al. Plantar temperatures in stance
position: A comparative study with healthy volunteers and
diabetes patients diagnosed with sensoric neuropathy.
EBioMedicine 2020; 54: 102712.
https://doi.org/10.1016/j.ebiom.2020.102712
Animaw W, Seyoum Y. Increasing prevalence of diabetes mellitus
in a developing country and its related factors. PLoS One 2017;
(11): e0187670. https://doi.org/10.1371/journal.pone.0187670
Aamir AH, Ul-Haq Z, Mahar SA, Qureshi FM, Ahmad I, Jawa A,
et al. Diabetes Prevalence Survey of Pakistan (DPS-PAK):
prevalence of type 2 diabetes mellitus and prediabetes using
HbA1c: a population-based survey from Pakistan. BMJ Open
; 9(2): e025300.
https://doi.org/10.1136/bmjopen-2018-025300
Adnan M, Aasim M. Prevalence of type 2 diabetes mellitus in
adult population of Pakistan: A meta-analysis of prospective
cross-sectional surveys. Ann Glob Health 2020; 86(1): 7.
https://doi.org/10.5334/aogh.2679
Ijaz M, Ali I, Hussain A. Diabetes mellitus in Pakistan: the past,
present, and future. Int J Diabetes Dev Ctries. 2020; 40(1): 153-154.
https://doi.org/10.1007/s13410-019-00754-x
IDF Diabetes Atlas. 9th Edition. International Diabetes
Federation; 2019.
Russo G, Piscitelli P, Giandalia A, Viazzi F, Pontremoli R, Fioretto
P, et al. Atherogenic dyslipidemia and diabetic nephropathy. J
Nephrol 2020; 33(5): 1001-1008.
https://doi.org/10.1007/s40620-020-00739-8
Tolonen N, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund
M, Saraheimo M, et al. Relationship between lipid profiles and
kidney function in patients with type 1 diabetes. Diabetologia
; 51(1): 12-20. https://doi.org/10.1007/s00125-007-0858-y
Palazhy S, Viswanathan V. Lipid abnormalities in type 2 diabetes
mellitus patients with overt nephropathy. Diabetes Metabol J
; 41(2): 128-134.
https://doi.org/10.4093%2Fdmj.2017.41.2.128
Naha S, Naha K, Pandit VR, Balasubramanian R. Association of
microalbuminuria with ischemic heart disease in non-diabetic
Asian-Indians: A case control study. Avicenna J Med 2015; 5(1): 6-
https://doi.org/10.4103%2F2231-0770.148501
Wang SH, Wang L, Zhou Y, Guo YJ, Yuan Y, Li FF, et al.
Prevalence and control of dyslipidaemia among diabetic patients
with microalbuminuria in a Chinese hospital. Diabetes Vasc Dis
Res 2013; 10(2): 169-178.
https://doi.org/10.1177/1479164112454756
Ahmad T, Ulhaq I, Mawani M, Islam N. Microalbuminuria in
Type-2 Diabetes Mellitus; the tip of iceberg of diabetic
complications. Pak J Med Sci 2017; 33(3): 519-523.
https://doi.org/10.12669%2Fpjms.333.12537
Tomlinson B, Patil NG, Fok M, Lam CWK. Managing
dyslipidemia in patients with Type 2 diabetes. Expert Opin
Pharmacother 2021; 22(16): 2221-2234.
https://doi.org/10.1080/14656566.2021.1912734
Lazarte J, Hegele RA. Dyslipidemia management in adults with
diabetes. Can J Diabetes 2020; 44(1): 53-60.
https://doi.org/10.1016/j.jcjd.2019.07.003
Zhang L, Qiao Q, Tuomilehto J, Hammar N, Janus ED, Söderberg
S, et al. Blood lipid levels in relation to glucose status in seven
populations of Asian origin without a prior history of diabetes:
the DECODA study. Diabetes Metab Res Rev 2009; 25(6): 549-557.
https://doi.org/10.1002/dmrr.994
Byrne P, Cullinan J, Smith SM. Statins for primary prevention of
cardiovascular disease. BMJ 2019; 367: 15674.
https://doi.org/10.1136/bmj.l5674
Aslan I, Kucuksayan E, Aslan M. Effect of insulin analog
initiation therapy on LDL/HDL subfraction profile and HDL
associated enzymes in type 2 diabetic patients. Lipids Health Dis
; 12: 54. https://doi.org/10.1186/1476-511X-12-54
Downloads
Published
Issue
Section
How to Cite
